{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-196195","form_type":"8-K","ticker":null,"cik":"0001501134","company_name":"Invitae Corp","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.272690+00:00","generated_at":"2026-05-31T10:51:48.340021+00:00","sec_items":["1.03","2.01","3.03","5.02","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Invitae sells business to Labcorp for $239M, exits Chapter 11; stock canceled","bullets":["Labcorp subsidiary acquired Invitae's business for $239M cash plus assumed liabilities; closed Aug 5, 2024.","Chapter 11 plan confirmed and effective Aug 7, 2024; all common stock canceled with no value.","Board of directors dissolved; CEO Kenneth D. Knight, CFO Ana J. Schrank, and other officers dismissed.","Debtors reported $394M total assets and $1,692M total liabilities as of June 30, 2024.","All existing notes, indentures, and equity interests discharged and cancelled."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-196195","json":"https://secwatch.observer/filing/0001193125-24-196195.json","markdown":"https://secwatch.observer/filing/0001193125-24-196195.md","text":"https://secwatch.observer/filing/0001193125-24-196195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/d859163d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:51:48.340021+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c5550a8928b086b2371f2fcd704d3ca0674b84ee","claim":"Invitae Corp entered chapter 11 in United States Bankruptcy Court District of New Jersey.","evidence_excerpt":"On July 22-23, 2024, the Bankruptcy Court held a confirmation hearing to approve the Company’s Third Amended Joint Plan of Invitae Corporation and Its Debtor Affiliates Pursuant to Chapter 11 of the Bankruptcy Code","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.9,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 11"},{"label":"Court","value":"United States Bankruptcy Court District of New Jersey"}],"fact_type":"distress_event"},{"claim_id":"019bd7a957","claim":"Jill Frizzley departed as Director at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"0c3466d513","claim":"Randal W. Scott departed as Director at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1e0f6cd24c","claim":"Ana J. Schrank departed as Chief Financial Officer at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"2d3e18a588","claim":"Thomas R. Brida departed as General Counsel, Chief Compliance Officer and Secretary at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"General Counsel, Chief Compliance Officer and Secretary"}],"fact_type":"executive_change"},{"claim_id":"7409f5cb0b","claim":"Eric Aguiar departed as Director at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"92bb6dd16c","claim":"Kimber D. Lockhart departed as Director at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"977547d3c7","claim":"William H. Osborne departed as Director at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b3898b74f1","claim":"Kenneth D. Knight departed as Chief Executive Officer at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b81b195826","claim":"Chitra Nayak departed as Director at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bd6a390082","claim":"David B. Sholehvar departed as Chief Operating Officer at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"c1d83b6a80","claim":"Geoffrey S. Crouse departed as Director at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f54e7e284b","claim":"Christine M. Gorjanc departed as Director at Invitae Corp.","evidence_excerpt":"Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000119312524196195/0001193125-24-196195-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}